Zura Bio Ltd

ZURA

Zura Bio Ltd

ZURA

Insider Sentiment (TTM):

Last Purchase:2026-02-26Last Sale:2024-11-25Shares Purchased (TTM):2,000,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:61,239,663Shares Outstanding:112,222,789Institutional Ownership Pct.:54.57%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	205	226	109	139	154	171	176	188	188	90	100	104
Other Prepaid Expense Current	-	-	-	-	-	-	-	-	1	1	1	1
Prepaid Expense And Other Assets Current	5	1	3	3	2	1	2	1	-	-	1	-
Assets Current	211	227	112	142	157	172	179	189	189	90	101	105
Deferred Costs	-	-	-	-	-	-	-	-	-	-	0	-
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	-	-
Other Assets Noncurrent	3	2	2	2	1	1	1	0	-	-	-	-
Assets	213	229	114	144	158	172	180	189	190	90	101	105
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	16	12	12	25	19	21	20	18	15	15	20	17
Liabilities Current	16	12	12	25	19	21	20	18	15	15	20	17
Shares Subject To Mandatory Redemption Settlement …	-	-	-	-	-	-	-	-	2	2	1	2
Liabilities	16	12	12	25	19	21	20	18	17	16	21	19
Temporary Equity
Redeemable Noncontrolling Interest Equity Carrying…	-	-	-	9	12	12	12	16	14	12	19	21
Stockholders Equity Inclu…
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	472	466	326	316	315	312	303	295	278	172	163	158
Retained Earnings Accumulated Deficit	-275	-249	-225	-207	-189	-173	-156	-142	-122	-111	-103	-95
Stockholders Equity	197	217	102	110	126	140	147	154	157	61	59	63
Minority Interest	-	-	-	2	2	2	2	2	2	2	2	2
Liabilities And Stockholders Equity	213	229	114	144	158	172	180	189	190	90	101	105
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Temporary Equity Shares Issued	-	-	-	-	-	-	-	-	-	-	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Temporary Equity Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0	0
Common Stock Shares Issued	95	95	74	65	62	68	65	65	64	44	44	43
Shares Outstanding	95	95	74	65	62	68	65	65	64	44	44	43
Preferred Stock Par Or Stated Value Per Share	-	0	-	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	-	1	-	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	-	-	-	0	0	0	0	0	-	0	0	0
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	-	-	-	-	-	0.001	0.001
Preferred Stock Shares Outstanding	-	-	-	0	0	0	0	0	0	0	0	0
Temporary Equity Shares Authorized	-	-	-	-	-	-	-	-	-	-	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-5.29%	17.84%	15.20%	-	-	-	-	-	-	-	-	-
2025	-19.84%	-16.67%	30.16%	27.91%	128.49%	123.26%	-10.53%	32.78%	35.89%	-7.68%	-21.73%	-44.44%
2024	14.13%	-23.91%	-15.43%	10.03%	33.13%	33.13%	-31.77%	-44.07%	-61.52%	-17.45%	-25.50%	-19.46%
2023	-	-	-	-10.50%	-2.33%	-28.86%	0.00%	1.50%	-17.50%	28.79%	135.41%	46.69%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	12.90	19.33	9.05	5.58	8.40	8.14	9.16	10.36	12.57	6.17	4.97	6.15
Quick Ratio	12.57	19.21	8.82	5.45	8.26	8.09	9.04	10.32	12.57	6.17	4.92	6.15
Working Capital	194.18M	215.26M	99.90M	116.80M	138.29M	150.60M	159.23M	170.73M	174.40M	75.80M	80.54M	87.58M
Leverage & Debt
Debt to Equity	0.08	0.05	0.12	0.23	0.15	0.15	0.13	0.12	0.11	0.27	0.35	0.30
Debt Ratio	0.08	0.05	0.11	0.18	0.12	0.12	0.11	0.10	0.09	0.18	0.21	0.18
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.92	-0.95	-1.06	-0.71	-0.72	-0.67	-0.60	-0.44	-0.34	-1.29	-2.09	-1.82
Free Cash Flow Per Share TTM	-0.45	-0.65	-0.69	-0.45	-0.06	-0.37	-0.37	-0.24	-0.24	-0.36	-0.46	-0.23
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	71.84%	70.91%	118.91%	75.45%	162.54%	2.84%	-34.45%	-55.17%	-66.97%	76.74%	113.78%	880.62%
EPS Growth (1Y)	27.78%	41.58%	74.53%	62.04%	108.68%	-48.10%	-71.13%	-75.94%	-84.88%	-86.62%	-98.52%	-91.98%
Valuation Metrics
P/E TTM	-6.42	-6.29	-4.97	-6.10	-1.46	-1.93	-4.14	-9.27	-10.16	-2.00	-2.23	-3.63
P/B TTM	3.80	3.08	4.86	3.73	0.79	0.86	1.27	2.30	1.68	1.98	2.54	4.89
Market Cap	748.14M	667.73M	493.40M	409.46M	99.00M	119.92M	187.68M	354.58M	262.32M	120.57M	154.41M	309.38M
Enterprise Value	747.94M	442.13M	383.99M	270.45M	98.85M	-50.65M	11.18M	166.36M	73.87M	30.75M	54.60M	205.52M
Calculated Values
Free Cash Flow TTM	-57.17M	-72.95M	-65.12M	-42.59M	-5.65M	-34.27M	-28.15M	-21.34M	-18.24M	-16.79M	-15.05M	-10.61M
Net Debt	-205.13K	-225.59M	-109.41M	-139.02M	-154.49K	-170.57M	-176.50M	-188.22M	-188.44M	-89.82M	-99.81M	-103.86M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-26Purchase

Owner: Access, Industries Holdin…

Title: -

Shares: 2,000,000

Price/Share: $6.25

Value: $12,500,000.00

Shares Owned: 6,552,725

Relationship: TenPercentOwner

Ownership: Direct

2024-11-25Sale

Owner: Thiara, Parvinder

Title: -

Shares: 1,001,633

Price/Share: $2.73

Value: $2,734,458.09

Shares Owned: -

Relationship: Director

Ownership: Indirect

2024-09-11Sale

Owner: Thiara, Parvinder

Title: -

Shares: 3,800,000

Price/Share: $2.70

Value: $10,260,000.00

Shares Owned: 1,001,633

Relationship: Director

Ownership: Indirect

2024-09-04Sale

Owner: Sidhu, Someit

Title: -

Shares: 51,728

Price/Share: $3.87

Value: $200,187.36

Shares Owned: 2,085,418

Relationship: Director

Ownership: Direct

2024-05-17Purchase

Owner: Ploos, Van Amstel Arnout

Title: -

Shares: 80,000

Price/Share: $6.20

Value: $496,000.00

Shares Owned: 100,000

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-26	Access, Industries Holdin…	TenPercentOwner	-	Direct	Purchase	2,000,000	6.25	$12,500,000.00	6,552,725	4
2024-11-25	Thiara, Parvinder	Director	-	Indirect	Sale	1,001,633	2.73	$2,734,458.09	0	4
2024-09-11	Thiara, Parvinder	Director	-	Indirect	Sale	3,800,000	2.70	$10,260,000.00	1,001,633	4
2024-09-04	Sidhu, Someit	Director	-	Direct	Sale	51,728	3.87	$200,187.36	2,085,418	4
2024-05-17	Ploos, Van Amstel Arnout	Director	-	Direct	Purchase	80,000	6.20	$496,000.00	100,000	4
2024-04-22	Munshi, Amit	Director	-	Direct	Purchase	159,744	3.13	$499,998.72	777,384	4
2024-04-22	Sidhu, Someit	Director	-	Indirect	Purchase	1,186,901	3.13	$3,715,000.13	1,186,901	4
2024-04-22	Howell, Michael	Officer	See Remarks	Indirect	Purchase	7,987	3.13	$24,999.31	7,987	4
2024-04-22	Nistala, Kiran	Officer	Executive Vice President	Direct	Purchase	3,195	3.13	$10,000.35	3,195	4
2023-12-12	Thiara, Parvinder	Director,TenPercentOwner	-	Indirect	Sale	2,000,000	4.00	$8,000,000.00	4,801,633	4
2023-06-05	Munshi, Amit	Director	-	Direct	Purchase	117,647	4.25	$499,999.75	617,640	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

54.57%

Inst. Shares: 61,239,663

Shares Outstanding: 112,222,789

2025-12-31

47.60%

Inst. Shares: 44,821,244

Shares Outstanding: 94,160,138

2025-09-30

43.44%

Inst. Shares: 41,079,305

Shares Outstanding: 94,564,632

2025-06-30

37.33%

Inst. Shares: 35,199,639

Shares Outstanding: 94,289,954

2025-03-31

49.04%

Inst. Shares: 45,586,990

Shares Outstanding: 92,964,048

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	61,239,663	112,222,789	54.57%
2025-12-31	44,821,244	94,160,138	47.60%
2025-09-30	41,079,305	94,564,632	43.44%
2025-06-30	35,199,639	94,289,954	37.33%
2025-03-31	45,586,990	92,964,048	49.04%
2024-12-31	42,662,888	75,070,761	56.83%
2024-09-30	37,017,174	87,335,667	42.38%
2024-06-30	32,828,657	74,947,369	43.80%
2024-03-31	14,861,457	46,914,542	31.68%
2023-12-31	15,102,504	33,064,036	45.68%
2023-09-30	13,960,087	46,876,344	29.78%
2023-06-30	12,654,365	34,303,125	36.89%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Zura Bio Ltd (ZURA) — SEC Financial Statements & Analysis

Zura Bio Ltd (ZURA) is a biological products, (no diagnostic substances) company, incorporated in E9. Zura Bio Ltd trades on Nasdaq as: ZURA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Zura Bio Ltd reported a Debt-to-Equity ratio of 0.08x, a Price-to-Book (P/B) ratio of 3.80x (TTM), at a market cap of $748.14M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.08x
P/B TTM: 3.80x
Market Cap: $748.14M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Zura Bio Ltd in?

Zura Bio Ltd (ZURA) operates in the Biological Products, (No Diagnostic Substances) industry.

What is ZURA's market cap?

Zura Bio Ltd (ZURA) has a market capitalization of $748.14M as of 2026-06-30.

What exchange does ZURA trade on?

Zura Bio Ltd (ZURA) trades on the Nasdaq.

Where is Zura Bio Ltd incorporated?

Zura Bio Ltd is incorporated in Cayman Islands.

Zura Bio Ltd

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Zura Bio Ltd (ZURA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

Zura Bio Ltd (ZURA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.